Artificial intelligence in histopathology: enhancing cancer research and clinical oncology

A Shmatko, N Ghaffari Laleh, M Gerstung, JN Kather - Nature cancer, 2022 - nature.com
Artificial intelligence (AI) methods have multiplied our capabilities to extract quantitative
information from digital histopathology images. AI is expected to reduce workload for human …

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

X He, X Liu, F Zuo, H Shi, J **g - Seminars in Cancer Biology, 2023 - Elsevier
With biotechnological advancements, innovative omics technologies are constantly
emerging that have enabled researchers to access multi-layer information from the genome …

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Y Li, TSM Lih, SM Dhanasekaran, R Mannan, L Chen… - Cancer Cell, 2023 - cell.com
Clear cell renal cell carcinomas (ccRCCs) represent∼ 75% of RCC cases and account for
most RCC-associated deaths. Inter-and intratumoral heterogeneity (ITH) results in varying …

Artificial intelligence for digital and computational pathology

AH Song, G Jaume, DFK Williamson, MY Lu… - Nature Reviews …, 2023 - nature.com
Advances in digitizing tissue slides and the fast-paced progress in artificial intelligence,
including deep learning, have boosted the field of computational pathology. This field holds …

Artificial intelligence to identify genetic alterations in conventional histopathology

D Cifci, S Foersch, JN Kather - The Journal of Pathology, 2022 - Wiley Online Library
Precision oncology relies on the identification of targetable molecular alterations in tumor
tissues. In many tumor types, a limited set of molecular tests is currently part of standard …

Using machine learning algorithms to predict immunotherapy response in patients with advanced melanoma

P Johannet, N Coudray, DM Donnelly, G Jour… - Clinical Cancer …, 2021 - AACR
Purpose: Several biomarkers of response to immune checkpoint inhibitors (ICI) show
potential but are not yet scalable to the clinic. We developed a pipeline that integrates deep …

Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined …

S Fremond, S Andani, JB Wolf, J Dijkstra… - The Lancet Digital …, 2023 - thelancet.com
Background Endometrial cancer can be molecularly classified into POLE mut, mismatch
repair deficient (MMRd), p53 abnormal (p53abn), and no specific molecular profile (NSMP) …

AI-based histopathology image analysis reveals a distinct subset of endometrial cancers

A Darbandsari, H Farahani, M Asadi, M Wiens… - Nature …, 2024 - nature.com
Endometrial cancer (EC) has four molecular subtypes with strong prognostic value and
therapeutic implications. The most common subtype (NSMP; No Specific Molecular Profile) …

From whole-slide image to biomarker prediction: end-to-end weakly supervised deep learning in computational pathology

OSM El Nahhas, M van Treeck, G Wölflein, M Unger… - Nature …, 2025 - nature.com
Hematoxylin-and eosin-stained whole-slide images (WSIs) are the foundation of diagnosis
of cancer. In recent years, development of deep learning-based methods in computational …

[HTML][HTML] Predicting gene mutation status via artificial intelligence technologies based on multimodal integration (MMI) to advance precision oncology

J Shao, J Ma, Q Zhang, W Li, C Wang - Seminars in cancer biology, 2023 - Elsevier
Personalized treatment strategies for cancer frequently rely on the detection of genetic
alterations which are determined by molecular biology assays. Historically, these processes …